$GLYC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GLYCOMIMETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GLYCOMIMETICS INC. Get notifications about new insider transactions in GLYCOMIMETICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | X | 0.33 | 9,445 | 3,117 | 4,491,203 | 4.5 M to 4.5 M (+0.21 %) |
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Option Exercise | X | 0.33 | 9,445 | 3,117 | 0 | |
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Sell | S | 6.91 | 452 | 3,123 | 4,490,751 | 4.5 M to 4.5 M (-0.01 %) |
Nov 18 2015 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | X | 0.33 | 9,445 | 3,117 | 4,491,203 | 4.5 M to 4.5 M (+0.21 %) |
Aug 11 2015 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
Aug 11 2015 | GLYC | GLYCOMIMETICS INC | PEARSON TIMOTHY R | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
Aug 11 2015 | GLYC | GLYCOMIMETICS INC | Baldwin John J. | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
Aug 11 2015 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
Aug 11 2015 | GLYC | GLYCOMIMETICS INC | TOP FRANKLIN H JR | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
Aug 11 2015 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
Mar 03 2015 | GLYC | GLYCOMIMETICS INC | Hahn Brian M. | CFO | Option Exercise | M | 1.12 | 5,000 | 5,600 | 10,520 | |
Mar 03 2015 | GLYC | GLYCOMIMETICS INC | Hahn Brian M. | CFO | Buy | M | 1.12 | 5,000 | 5,600 | 14,085 | 9.1 K to 14.1 K (+55.04 %) |
Feb 26 2015 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | M | 1.12 | 50,000 | 56,000 | 297,580 | |
Feb 26 2015 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Buy | M | 1.12 | 50,000 | 56,000 | 167,206 | 117.2 K to 167.2 K (+42.66 %) |
Jan 12 2015 | GLYC | GLYCOMIMETICS INC | Magnani John L. | VP of Research, CSO | Option Exercise | A | 7.15 | 71,000 | 507,650 | 71,000 | |
Jan 12 2015 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Option Exercise | A | 7.15 | 71,000 | 507,650 | 71,000 | |
Jan 12 2015 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | A | 7.15 | 141,000 | 1,008,150 | 141,000 | |
Jan 12 2015 | GLYC | GLYCOMIMETICS INC | Hahn Brian M. | CFO | Option Exercise | A | 7.15 | 61,000 | 436,150 | 61,000 | |
Dec 23 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Sell | S | 8.44 | 10,659 | 89,913 | 469,454 | 480.1 K to 469.5 K (-2.22 %) |
Dec 23 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Sell | S | 8.61 | 10,598 | 91,277 | 480,113 | 490.7 K to 480.1 K (-2.16 %) |
Dec 17 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | X | 0.33 | 38,493 | 12,703 | 0 | |
Dec 17 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | X | 0.33 | 5,133 | 1,694 | 0 | |
Dec 17 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Sell | S | 8.97 | 5,121 | 45,935 | 490,711 | 495.8 K to 490.7 K (-1.03 %) |
Dec 17 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Sell | S | 8.98 | 1,604 | 14,404 | 495,832 | 497.4 K to 495.8 K (-0.32 %) |
Dec 17 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Buy | X | 0.33 | 43,628 | 14,397 | 497,436 | 453.8 K to 497.4 K (+9.61 %) |
Jul 10 2014 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 8.86 | 15,401 | 136,453 | 15,401 | |
Jun 20 2014 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | M | 1.12 | 100,000 | 112,000 | 347,580 | |
Jun 20 2014 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Buy | M | 1.12 | 100,000 | 112,000 | 108,706 | 8.7 K to 108.7 K (+1,148.63 %) |
Jun 13 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Buy | P | 6.21 | 5,000 | 31,050 | 12,562 | 7.6 K to 12.6 K (+66.12 %) |
Jun 13 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Buy | P | 6.54 | 6,000 | 39,240 | 7,562 | 1.6 K to 7.6 K (+384.12 %) |
Apr 03 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | M | 1.12 | 1,562 | 1,749 | 0 | |
Apr 03 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Buy | M | 1.12 | 1,562 | 1,749 | 1,562 | 0 to 1.6 K |
Apr 01 2014 | GLYC | GLYCOMIMETICS INC | PEARSON TIMOTHY R | Director | Option Exercise | A | 16.33 | 15,401 | 251,498 | 15,401 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | Magnani John L. | VP of Research, CSO | Option Exercise | C | 0.00 | 32,918 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | Magnani John L. | VP of Research, CSO | Sell | C | 0.00 | 9,969 | 0 | 90,374 | 100.3 K to 90.4 K (-9.93 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | C | 0.00 | 1,114,690 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | C | 0.00 | 39,413 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Buy | C | 0.00 | 337,579 | 0 | 453,808 | 116.2 K to 453.8 K (+290.44 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Buy | C | 0.00 | 11,936 | 0 | 22,668 | 10.7 K to 22.7 K (+111.22 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | Gust William M. | Director | Option Exercise | C | 0.00 | 1,121,646 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | Gust William M. | Director | Buy | C | 0.00 | 339,686 | 0 | 409,947 | 70.3 K to 409.9 K (+483.46 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 11,824,058 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 11,250,850 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Buy | P | 8.00 | 512,500 | 4,100,000 | 4,093,377 | 3.6 M to 4.1 M (+14.31 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 3,580,877 | 0 | 3,580,877 | 0 to 3.6 M |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Buy | P | 8.00 | 487,500 | 3,900,000 | 4,481,758 | 4 M to 4.5 M (+12.21 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 3,407,283 | 0 | 3,994,258 | 587 K to 4 M (+580.48 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 11,824,058 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 11,250,850 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | P | 8.00 | 512,500 | 4,100,000 | 4,093,377 | 3.6 M to 4.1 M (+14.31 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,580,877 | 0 | 3,580,877 | 0 to 3.6 M |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | P | 8.00 | 487,500 | 3,900,000 | 4,481,758 | 4 M to 4.5 M (+12.21 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,407,283 | 0 | 3,994,258 | 587 K to 4 M (+580.48 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | C | 0.00 | 11,824,058 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | C | 0.00 | 11,250,850 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | P | 8.00 | 512,500 | 4,100,000 | 4,093,377 | 3.6 M to 4.1 M (+14.31 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | C | 0.00 | 3,580,877 | 0 | 3,580,877 | 0 to 3.6 M |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | P | 8.00 | 487,500 | 3,900,000 | 4,481,758 | 4 M to 4.5 M (+12.21 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Buy | C | 0.00 | 3,407,283 | 0 | 3,994,258 | 587 K to 4 M (+580.48 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 11,824,058 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 8.00 | 512,500 | 4,100,000 | 4,093,377 | 3.6 M to 4.1 M (+14.31 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 3,580,877 | 0 | 3,580,877 | 0 to 3.6 M |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Option Exercise | C | 0.00 | 11,250,850 | 0 | 0 | |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | P | 8.00 | 487,500 | 3,900,000 | 4,481,758 | 4 M to 4.5 M (+12.21 %) |
Jan 15 2014 | GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | C | 0.00 | 3,407,283 | 0 | 3,994,258 | 587 K to 4 M (+580.48 %) |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Option Exercise | A | 8.00 | 112,692 | 901,536 | 112,692 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | TOP FRANKLIN H JR | Director | Option Exercise | A | 8.00 | 15,401 | 123,208 | 15,401 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | Magnani John L. | VP of Research, CSO | Option Exercise | A | 8.00 | 169,038 | 1,352,304 | 169,038 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Option Exercise | A | 8.00 | 15,401 | 123,208 | 15,401 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | A | 8.00 | 375,639 | 3,005,112 | 375,639 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | Hahn Brian M. | CFO | Option Exercise | A | 8.00 | 37,564 | 300,512 | 37,564 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | Gust William M. | Director | Option Exercise | A | 8.00 | 15,401 | 123,208 | 15,401 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | Baldwin John J. | Director | Option Exercise | A | 8.00 | 15,401 | 123,208 | 15,401 | |
Jan 13 2014 | GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Option Exercise | A | 8.00 | 15,401 | 123,208 | 15,401 |